
IndraLab
Statements
reach
"Of note, MK‐2206 exhibited the most prominent enhancement of ESR1 expression in CCL23‐overexpressed HepG2 cells (Figure 5E), consistent with the previous observation that the activation of AKT could inactivate FOXO3A, leading to reduced transcription of ESR1 (encoding ERα) in breast cancer cells.24, 25 In line with these data, interference of CCL23 increased AKT phosphorylation and decreased ESR1 protein level, whereas inhibition of AKT by MK‐2206 in siCCL23‐treated HepG2 cells rescued the expression of ESR1 protein (Figure 5F)."